![]()

Lighthouse
Medical Communications US (part of the Lucid Group) is pleased to announce the
appointment of Andy Willmer to the position of Managing Director, leading the
US operation and championing the growth of the group in the US market. Andy
will lead the communications team in the delivery of exceptional medical
education and disease understanding programmes, publications and communications
planning, peer-to-peer medical communications and medical advocacy
development.
Andy brings
an abundance of pharmaceutical, healthcare marketing and brand communications experience,
having previously held senior positions within Pharmacia, Biovail and Roche,
and most recently on the agency side with Ogilvy CommonHealth in the USA, where he held the position
of General Manager, Medical Marketing.
Lighthouse
Medical Communications has experienced rapid growth since it was founded in
2014, predominately capitalising on US domestic business opportunities, with a
view to expanding programmes on a global level. Lighthouse already has an
impressive client roster and has been busy focusing on the needs of their clients,
primarily working in womens’ health and novel biologic immuno-oncologic
therapies.
Dennis O’Brien
(Lucid CEO and Co-Founder) commented, “Andy is a great fit with the team – and
his history and experience in US and Global Pharma communications, both agency
and client side, made him the ideal choice to head the Lighthouse
Communications team in the US. Andy shares our passion to create
magical programmes that transform patients’ lives by improving outcomes”
“I’m
thrilled to be leading such a smart and dynamic team. The Lighthouse (Lucid)
approach of building strategic medical communications which can change lives is
rewarding and where I want to be.” commented Andy.
Andy can be
contacted at: E: andy@weareteamlighthouse.com
T: +1 646 710 7736
M: +1 908 200 1145